The Diagnostic Potential of Amyloidogenic Proteins

Neurodegenerative disorders are a highly prevalent class of diseases, whose pathological mechanisms start before the appearance of any clear symptoms. This fact has prompted scientists to search for biomarkers that could aid early treatment. These currently incurable pathologies share the presence o...

Full description

Bibliographic Details
Main Authors: Yiyun Jin, Devkee Mahesh Vadukul, Dimitra Gialama, Ying Ge, Rebecca Thrush, Joe Thomas White, Francesco Antonio Aprile
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/8/4128
_version_ 1797537492821344256
author Yiyun Jin
Devkee Mahesh Vadukul
Dimitra Gialama
Ying Ge
Rebecca Thrush
Joe Thomas White
Francesco Antonio Aprile
author_facet Yiyun Jin
Devkee Mahesh Vadukul
Dimitra Gialama
Ying Ge
Rebecca Thrush
Joe Thomas White
Francesco Antonio Aprile
author_sort Yiyun Jin
collection DOAJ
description Neurodegenerative disorders are a highly prevalent class of diseases, whose pathological mechanisms start before the appearance of any clear symptoms. This fact has prompted scientists to search for biomarkers that could aid early treatment. These currently incurable pathologies share the presence of aberrant aggregates called amyloids in the nervous system, which are composed of specific proteins. In this review, we discuss how these proteins, their conformations and modifications could be exploited as biomarkers for diagnostic purposes. We focus on proteins that are associated with the most prevalent neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases, amyotrophic lateral sclerosis, and frontotemporal dementia. We also describe current challenges in detection, the most recent techniques with diagnostic potentials and possible future developments in diagnosis.
first_indexed 2024-03-10T12:15:58Z
format Article
id doaj.art-f9fffe71e60c4cb0b7b0432f5622eac7
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T12:15:58Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-f9fffe71e60c4cb0b7b0432f5622eac72023-11-21T15:52:32ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01228412810.3390/ijms22084128The Diagnostic Potential of Amyloidogenic ProteinsYiyun Jin0Devkee Mahesh Vadukul1Dimitra Gialama2Ying Ge3Rebecca Thrush4Joe Thomas White5Francesco Antonio Aprile6Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UKDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UKDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UKDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UKDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UKDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UKDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UKNeurodegenerative disorders are a highly prevalent class of diseases, whose pathological mechanisms start before the appearance of any clear symptoms. This fact has prompted scientists to search for biomarkers that could aid early treatment. These currently incurable pathologies share the presence of aberrant aggregates called amyloids in the nervous system, which are composed of specific proteins. In this review, we discuss how these proteins, their conformations and modifications could be exploited as biomarkers for diagnostic purposes. We focus on proteins that are associated with the most prevalent neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases, amyotrophic lateral sclerosis, and frontotemporal dementia. We also describe current challenges in detection, the most recent techniques with diagnostic potentials and possible future developments in diagnosis.https://www.mdpi.com/1422-0067/22/8/4128neurodegenerative diseasesbiomarkeramyloidoligomerpost-translational modification
spellingShingle Yiyun Jin
Devkee Mahesh Vadukul
Dimitra Gialama
Ying Ge
Rebecca Thrush
Joe Thomas White
Francesco Antonio Aprile
The Diagnostic Potential of Amyloidogenic Proteins
International Journal of Molecular Sciences
neurodegenerative diseases
biomarker
amyloid
oligomer
post-translational modification
title The Diagnostic Potential of Amyloidogenic Proteins
title_full The Diagnostic Potential of Amyloidogenic Proteins
title_fullStr The Diagnostic Potential of Amyloidogenic Proteins
title_full_unstemmed The Diagnostic Potential of Amyloidogenic Proteins
title_short The Diagnostic Potential of Amyloidogenic Proteins
title_sort diagnostic potential of amyloidogenic proteins
topic neurodegenerative diseases
biomarker
amyloid
oligomer
post-translational modification
url https://www.mdpi.com/1422-0067/22/8/4128
work_keys_str_mv AT yiyunjin thediagnosticpotentialofamyloidogenicproteins
AT devkeemaheshvadukul thediagnosticpotentialofamyloidogenicproteins
AT dimitragialama thediagnosticpotentialofamyloidogenicproteins
AT yingge thediagnosticpotentialofamyloidogenicproteins
AT rebeccathrush thediagnosticpotentialofamyloidogenicproteins
AT joethomaswhite thediagnosticpotentialofamyloidogenicproteins
AT francescoantonioaprile thediagnosticpotentialofamyloidogenicproteins
AT yiyunjin diagnosticpotentialofamyloidogenicproteins
AT devkeemaheshvadukul diagnosticpotentialofamyloidogenicproteins
AT dimitragialama diagnosticpotentialofamyloidogenicproteins
AT yingge diagnosticpotentialofamyloidogenicproteins
AT rebeccathrush diagnosticpotentialofamyloidogenicproteins
AT joethomaswhite diagnosticpotentialofamyloidogenicproteins
AT francescoantonioaprile diagnosticpotentialofamyloidogenicproteins